India to Spain: Imatinib Export Trade Route
India has recorded 10 verified shipments of Imatinib exported to Spain, representing a combined trade value of $631.6K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $63.2K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 81% of total export value with 4 shipments worth $511.6K USD. On the buying side, ACCORD HEALTHCARE SLU is the largest importer in Spain with $360.1K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, GLOBELA PHARMA PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Spain Imatinib corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $631.6K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 81% of all export value, reflecting the consolidated nature of India's imatinib manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $63.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with imatinib's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 34.2%, placing it at rank #16 among India's top imatinib export destinations globally.
On the import side, key buyers of Indian imatinib in Spain include ACCORD HEALTHCARE SLU, XXCORXXHEAXXHCAXX SXX, LINDMED TRADE, S L and 2 others. ACCORD HEALTHCARE SLU is the single largest importer with 3 shipments valued at $360.1K USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ4
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#16
- Annual growth+34.2%
- Demand growth+28.4%
- Regulatory ease88/100
Top 10 Indian Imatinib Exporters to Spain
Showing top 10 of 4 Indian suppliers exporting Imatinib to Spain, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $127.9K per shipment | 4 | $511.6K | 81.0% |
| 2 | INTAS PHARMACEUTICALS LTD Avg $104.3K per shipment | 1 | $104.3K | 16.5% |
| 3 | GLOBELA PHARMA PRIVATE LIMITED Avg $14.9K per shipment | 1 | $14.9K | 2.4% |
| 4 | GALAXY SUPER SPECIALITY Avg $173 per shipment | 4 | $694 | 0.1% |
This table shows the top 10 of 4 Indian companies exporting imatinib to Spain, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, GLOBELA PHARMA PRIVATE LIMITED, GALAXY SUPER SPECIALITY. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 4 shipments worth $511.6K USD, giving it a 81% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Imatinib Importers in Spain
Showing top 10 of 5 known buyers in Spain receiving Imatinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian imatinib in Spain include ACCORD HEALTHCARE SLU, XXCORXXHEAXXHCAXX SXX, LINDMED TRADE, S L, TO THE ORDER OF, GLOBAL AVIATION SERVICES CARGO. The largest importer is ACCORD HEALTHCARE SLU, accounting for $360.1K USD across 3 shipments — representing 57% of all imatinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ACCORD HEALTHCARE SLU | 3 | $360.1K | 57.0% |
| 2 | XXCORXXHEAXXHCAXX SXX | 2 | $255.9K | 40.5% |
| 3 | LINDMED TRADE, S L | 1 | $14.9K | 2.4% |
| 4 | TO THE ORDER OF | 2 | $547 | 0.1% |
| 5 | GLOBAL AVIATION SERVICES CARGO | 2 | $147 | 0.0% |
Top 10 Imatinib Formulations Imported by Spain
Showing top 10 of 7 product formulations shipped on the India to Spain Imatinib route, ranked by trade value
Spain imports a wide range of imatinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — IMATINIB 400MG 3X10T ALU ACCORD-PP-ES — accounts for $300.0K USD across 2 shipments. A total of 7 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IMATINIB 400MG 3X10T ALU ACCORD-PP-ES | 2 | $300.0K | 47.5% |
| 2 | IMATINIB 400MG 3X10T ALU (ACCORD-PP-ES | 1 | $195.7K | 31.0% |
| 3 | IMATINIB 100MG 6X10T ALU (ACCORD-PP-FR | 1 | $60.1K | 9.5% |
| 4 | IMATINIB 100MG 6X10T ALU ACCORD-PP-FR | 1 | $60.0K | 9.5% |
| 5 | GLOMATINIB 400( SPAIN) IH IMATINIB TABLETS 400MG-BATCH NO.GST23169-MFG.DT.10/2023-EXP. DT.09/2026 | 1 | $14.9K | 2.4% |
| 6 | IMATIKAST- 400MG IMATINIB TAB IP 400MG BATCH NO.BT24481B MFG DT.12/2024,EXP DT.11/2026 | 2 | $547 | 0.1% |
| 7 | IMATIKAST- 400MG IMATINIB TAB 400MG BATC | 2 | $147 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 4 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's imatinib exports to Spain are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Spain benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, GLOBELA PHARMA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $63.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as imatinib 400mg 3x10t alu (accord-pp-es and imatinib 100mg 6x10t alu (accord-pp-fr, suggesting that buyers in Spain tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ACCORD HEALTHCARE SLU is the largest importer with 3 shipments worth $360.1K USD — representing 57% of all imatinib imports from India on this route.
Route Statistics
- Trade Volume
- $631.6K
- Avg. Shipment
- $63.2K
- Suppliers
- 4
- Buyers
- 5
- Transit (Sea)
- ~28 days
- Annual Growth
- +34.2%
Other Imatinib Routes
Unlock the Full India to Spain Imatinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 10 shipments on this route.
Frequently Asked Questions — India to Spain Imatinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Imatinib to Spain?
The leading Indian exporters of Imatinib to Spain are INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD, GLOBELA PHARMA PRIVATE LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 81% of total trade value on this route.
Q What is the total value of Imatinib exports from India to Spain?
India exports Imatinib to Spain worth approximately $631.6K USD across 10 recorded shipments. The average value per shipment is $63.2K USD.
Q Which ports does India use to ship Imatinib to Spain?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 4 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Spain for Imatinib?
The average transit time for Imatinib shipments from India to Spain is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Spain Imatinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 34.2% with demand growth tracking at 28.4%. The route is ranked #16 among India's top Imatinib export destinations globally.
Q How many suppliers are active on the India to Spain Imatinib route?
There are currently 4 active Indian suppliers exporting Imatinib to Spain. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 81% of total shipment value.
Q Who are the main importers of Imatinib from India in Spain?
The leading importers of Indian Imatinib in Spain include ACCORD HEALTHCARE SLU, XXCORXXHEAXXHCAXX SXX, LINDMED TRADE, S L, TO THE ORDER OF, GLOBAL AVIATION SERVICES CARGO. ACCORD HEALTHCARE SLU is the largest buyer with 3 shipments worth $360.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Spain export trade corridor identified from Indian Customs (DGFT) records for Imatinib.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 5 importers in Spain matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 10 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists